Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients

NCT05410275 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hemodialysis Patients

Interventions

DRUG: Rivaroxaban

Sponsor

University Hospital, Tours